BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36524006)

  • 41. Pan-cancer analysis of UBE2T with a focus on prognostic and immunological roles in lung adenocarcinoma.
    Cao K; Ling X; Jiang X; Ma J; Zhu J
    Respir Res; 2022 Nov; 23(1):306. PubMed ID: 36357897
    [TBL] [Abstract][Full Text] [Related]  

  • 42. KDF1 Promoted Proliferation and Metastasis of Epithelial Ovarian Cancer
    Zhu C; Liu Y; Tong R; Guan J
    Front Genet; 2022; 13():808100. PubMed ID: 35281796
    [No Abstract]   [Full Text] [Related]  

  • 43. Potential Prognostic Immune Biomarkers of Overall Survival in Ovarian Cancer Through Comprehensive Bioinformatics Analysis: A Novel Artificial Intelligence Survival Prediction System.
    He T; Huang L; Li J; Wang P; Zhang Z
    Front Med (Lausanne); 2021; 8():587496. PubMed ID: 34109184
    [No Abstract]   [Full Text] [Related]  

  • 44. [High expression of STAT2 in ovarian cancer and its effect on metastasis of ovarian cancer cells].
    Chen X; Huang J; Lü Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jan; 40(1):34-41. PubMed ID: 32376554
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The signal transducers Stat1 and Stat3 and their novel target Jmjd3 drive the expression of inflammatory genes in microglia.
    Przanowski P; Dabrowski M; Ellert-Miklaszewska A; Kloss M; Mieczkowski J; Kaza B; Ronowicz A; Hu F; Piotrowski A; Kettenmann H; Komorowski J; Kaminska B
    J Mol Med (Berl); 2014 Mar; 92(3):239-54. PubMed ID: 24097101
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer.
    Song Y; Qu H
    BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Comprehensive Risk Assessment Model for Ovarian Cancer Patients with
    Wang X; Lin FK; Li JR; Wang HS
    Onco Targets Ther; 2020; 13():5617-5628. PubMed ID: 32606776
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PER1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Ovarian Cancer.
    Chen M; Zhang L; Liu X; Ma Z; Lv L
    Front Genet; 2021; 12():697471. PubMed ID: 34220965
    [No Abstract]   [Full Text] [Related]  

  • 50. The long non-coding RNA T cell leukemia homeobox 1 neighbor enhances signal transducer and activator of transcription 5A phosphorylation to promote colon cancer cell invasion, migration, and metastasis.
    Chen G; Lian D; Zhao L; Wang Z; Wuyun Q; Zhang N
    Bioengineered; 2022 Apr; 13(4):11083-11095. PubMed ID: 35502613
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selective activation of members of the signal transducers and activators of transcription family in prostate carcinoma.
    Ni Z; Lou W; Lee SO; Dhir R; DeMiguel F; Grandis JR; Gao AC
    J Urol; 2002 Apr; 167(4):1859-62. PubMed ID: 11912448
    [TBL] [Abstract][Full Text] [Related]  

  • 52. VEGF, VEGFRs expressions and activated STATs in ovarian epithelial carcinoma.
    Chen H; Ye D; Xie X; Chen B; Lu W
    Gynecol Oncol; 2004 Sep; 94(3):630-5. PubMed ID: 15350351
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Ras homologue member I directly inhibits signal transducers and activators of transcription 3 translocation and activity in human breast and ovarian cancer cells.
    Nishimoto A; Yu Y; Lu Z; Mao X; Ren Z; Watowich SS; Mills GB; Liao WS; Chen X; Bast RC; Luo RZ
    Cancer Res; 2005 Aug; 65(15):6701-10. PubMed ID: 16061651
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification and Validation of an m6A Modification of JAK-STAT Signaling Pathway-Related Prognostic Prediction Model in Gastric Cancer.
    Jiang F; Chen X; Shen Y; Shen X
    Front Genet; 2022; 13():891744. PubMed ID: 35928449
    [No Abstract]   [Full Text] [Related]  

  • 55. Prognostic implications of PPL expression in ovarian cancer.
    Hua T; Zhao BB; Fan SB; Zhao CF; Kong YH; Tian RQ; Zhang BY
    Discov Oncol; 2022 May; 13(1):35. PubMed ID: 35612641
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Several genes involved in the JAK-STAT pathway may act as prognostic markers in pancreatic cancer identified by microarray data analysis.
    Pang C; Gu Y; Ding Y; Ma C; Yv W; Wang Q; Meng B
    Medicine (Baltimore); 2018 Dec; 97(50):e13297. PubMed ID: 30557977
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic value of key genes of the JAK-STAT signaling pathway in patients with cutaneous melanoma.
    Pan F; Wang Q; Li S; Huang R; Wang X; Liao X; Mo H; Zhang L; Zhou X
    Oncol Lett; 2020 Mar; 19(3):1928-1946. PubMed ID: 32194688
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential expression of signal transducers and activators of transcription during human adipogenesis.
    Harp JB; Franklin D; Vanderpuije AA; Gimble JM
    Biochem Biophys Res Commun; 2001 Mar; 281(4):907-12. PubMed ID: 11237746
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Abnormal spindle-like microcephaly-associated protein promotes proliferation by regulating cell cycle in epithelial ovarian cancer.
    Wu Y; You Y; Chen L; Liu Y; Liu Y; Lou W; Fu F
    Gland Surg; 2022 Apr; 11(4):687-701. PubMed ID: 35531115
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PPARgamma ligand-dependent induction of STAT1, STAT5A, and STAT5B during adipogenesis.
    Stephens JM; Morrison RF; Wu Z; Farmer SR
    Biochem Biophys Res Commun; 1999 Aug; 262(1):216-22. PubMed ID: 10448095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.